PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
27-Apr-2023 MiNA Therapeutics Enters Research Collaboration with BioMarin Pharmaceutical to Advance RNAa Platform Research in Rare Genetic Diseases MiNA Therapeutics
27-Apr-2023 Creative Proteomics Streamlines Your Drug Development Process with Its Peptide Characterization Service Creative Proteomics
27-Apr-2023 Alfa Chemistry Expresses Gratitude to Everyone Who Visited Its Booth at the ACS Spring 2023 Conference Alfa Chemistry
27-Apr-2023 CD Formulation Unveils Its Latest Offering: A Comprehensive Line of Pharmaceutical Formulation Characterization Testing Services CD Formulation
26-Apr-2023 ValiRx and Physiomics join forces to provide seamless data integration ValiRx
26-Apr-2023 CONSTRUCTION COMMENCES AT MODERNA INNOVATION AND TECHNOLOGY CENTRE IN THE UK Moderna
25-Apr-2023 Orgenesis CEO Vered Caplan featured in keynote series at INTERPHEX conference to discuss innovations in cell & gene therapy manufacturing Orgenesis
25-Apr-2023 Minoryx presents positive interim results from NEXUS registration study for leriglitazone targeting pediatric ALD patients with cerebral adrenoleukodystrophy (cALD) Minoryx Therapeutics
25-Apr-2023 CD Formulation Enhances Its Food Ingredients Lineup with Upgraded Acidity Regulators, Anticaking Agents, and Coating Agents CD Formulation
25-Apr-2023 Alfa Chemistry Newly Introduces Three APIs to Meet Market Demands: Tofacitinib Citrate, Tamoxifen Citrate, and Epalrestat Alfa Chemistry
25-Apr-2023 ImmunOs Therapeutics Appoints Michael A. Curran, PhD, as Chairman of its Scientific Advisory Board ImmunOs Therapeutics
24-Apr-2023 Championing sustainability and innovation at Lab Innovations 2023 Lab Innovations
20-Apr-2023 OMass Therapeutics Announces New Phase of Growth with Move to New Facilities and Team Expansion to Support Portfolio Progress OMass Therapeutics
19-Apr-2023 Alfa Chemistry-A New Supplier of Vaccine Excipients, Nucleic Acid Delivery Excipients and SARS-CoV-2 Detection Raw Materials Alfa Chemistry
18-Apr-2023 Tiziana Life Sciences Initiates Program to Develop Intranasal Foralumab in Type 1 Diabetes Tiziana Life Sciences
18-Apr-2023 Transgene - Preclinical Results Showing TG6050, a Novel Oncolytic Virus, induces Tumor Regression by Activating Innate and Adaptive immune responses presented at AACR Transgene
18-Apr-2023 Pneumagen further strengthens IP protection for lead product Neumifil with granting of US composition of matter patent Pneumagen
18-Apr-2023 Ariceum Therapeutics Announces Extension of Series A Financing to EUR 47.75M to Advance its Next Generation Radiopharmaceutical Clinical Pipeline Ariceum Therapeutics
18-Apr-2023 New Data Showing that Transgene and NEC’s Individualized Cancer Vaccine TG4050 Induces Strong and Specific Immune Responses against Tumors Presented at AACR 2023 Transgene
18-Apr-2023 XBiotech Announces First Subject Enrollment in Phase I Clinical Trial for Hutrukin, a Novel Candidate Therapy for Stroke XBiotech